Unknown

Dataset Information

0

Dietary choline, via gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α.


ABSTRACT: Chronic kidney disease (CKD) is a global public health problem that shortens lifespan primarily by increasing the risk of cardiovascular diseases. Trimethylamine-N-oxide (TMAO), a gut microbiota-derived toxin produced by metabolizing high-choline or carnitine foods, is associated with cardiovascular events in patients with CKD. Although the deleterious effect of TMAO on CKD-induced cardiac injury has been confirmed by various researches, the mechanisms remain unclear. Here, we tested the hypothesis that TMAO aggravates CKD-induced cardiac injury and explores the potential mechanism. CD1 mice underwent 5/6 nephrectomy to induce CKD, and then fed with a diet supplemented with choline (1.2% total) for 8 weeks. Serum TMAO levels were elevated in CKD mice compared with SHAM group, and higher TMAO levels were found in choline-supplemented CKD mice compared with CKD group. Dietary choline aggravated CKD-induced cardiac dysfunction, and reducing TMAO levels via medicinal charcoal tablets improved cardiac dysfunction. RNA-seq analysis revealed that dietary choline affected cardiac angiogenesis in CKD mice. Reduced cardiac capillary density and expressions of angiogenesis-related genes were observed in choline-treated CKD mice. Furthermore, dietary choline inhibited cardiac Hif-1α protein level in CKD mice, and Hif-1α stabilizer FG-4592 could improve cardiac angiogenesis and dysfunction in CKD mice on a high-choline diet. In conclusion, these data indicate that dietary choline, via gut microbe-generated TMAO, inhibits cardiac angiogenesis by reducing Hif-1α protein level, ultimately aggravates cardiac dysfunction in CKD mice.

SUBMITTER: Xie F 

PROVIDER: S-EPMC9669413 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dietary choline, <i>via</i> gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α.

Xie Feifei F   Zhen Xin X   Liu Zhuoliang Z   Chen Xiaomei X   Liu Zhuanhua Z   Zhou Miaomiao M   Zhou Zhanmei Z   Hu Zheng Z   Zhu Fengxin F   Huang Qiaobing Q   Zhang Lei L   Nie Jing J  

Frontiers in physiology 20221103


Chronic kidney disease (CKD) is a global public health problem that shortens lifespan primarily by increasing the risk of cardiovascular diseases. Trimethylamine-N-oxide (TMAO), a gut microbiota-derived toxin produced by metabolizing high-choline or carnitine foods, is associated with cardiovascular events in patients with CKD. Although the deleterious effect of TMAO on CKD-induced cardiac injury has been confirmed by various researches, the mechanisms remain unclear. Here, we tested the hypothe  ...[more]

Similar Datasets

| S-EPMC8052457 | biostudies-literature
| S-EPMC4943035 | biostudies-literature
| S-EPMC8408632 | biostudies-literature
2022-06-07 | GSE190203 | GEO
| S-EPMC8813054 | biostudies-literature
2021-03-31 | GSE157925 | GEO
| S-EPMC6529247 | biostudies-literature
| S-EPMC8950610 | biostudies-literature
| S-EPMC5944581 | biostudies-literature
| S-EPMC9287188 | biostudies-literature